Edinburgh, UK, 22nd June 2018 / Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ ca
Edinburgh, UK, 3rd May 2018 / Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from
Edinburgh, UK, 23rd April 2018 / Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducibl
The research and development agreement will develop synthetic promoters for use in immune system cells including lymphoid, myeloid and microglia cells.
Synpromics announces the appointment of Sarah Haecker Meeks, PhD to the position of Vice President, Business Development.